3Simon TL, Alverson DC, AuBuchon J, et al. Practice parameter for the use of red cell transfusions: developed by the Red Blood Coil Administration Practice Guidelines Development Task Force of the College of American Pathologists [J]. Arch Pathol Lab Med, 1998,122(2):130- 138. 被引量：1
4Rizzo JD, Linchtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and American Society of Hematology [J]. J Clin Oncol,2002,20(19) :4083 - 4107. 被引量：1
5Ozer H, Armitage JO, Bennett CL, et al. Update of recommendations of hematopoietic colony stimulating factors: evidence-based clinical practice guidelines [J]. J Clin Oncol,2000,18(20) :3558 - 3585. 被引量：1
6Huvel K, Engert A. Clinical applications of granulocyte colony-stimulating factor:an update and summary [J]. Ann Hematol,2003,82(4):207- 213. 被引量：1
7Schiffer CA, Anderson KC, Bennett CL, et al: Platelet transfusion for patient with cancer: clinical practice guidelines of the American Society of Clinical Oncology [J]. J Clin Oncol,2001,19(5) : 1519 - 1538. 被引量：1
8Talcott JA,Siegel RD, Finberg R,et al. Risk assessment in cancer patients with fever and neutopenia: a prospective two cancer validation of a prediction rule [ J ]. J Clin Oncol,1992,10(2) : 316- 322. 被引量：1
